United Free Cash Flow vs Interest Expense Analysis

UTHR Stock  USD 243.27  4.59  1.85%   
United Therapeutics financial indicator trend analysis is much more than just breaking down United Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether United Therapeutics is a good investment. Please check the relationship between United Therapeutics Free Cash Flow and its Interest Expense accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.

Free Cash Flow vs Interest Expense

Free Cash Flow vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of United Therapeutics Free Cash Flow account and Interest Expense. At this time, the significance of the direction appears to have very week relationship.
The correlation between United Therapeutics' Free Cash Flow and Interest Expense is 0.29. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Interest Expense in the same time period over historical financial statements of United Therapeutics, assuming nothing else is changed. The correlation between historical values of United Therapeutics' Free Cash Flow and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of United Therapeutics are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Free Cash Flow i.e., United Therapeutics' Free Cash Flow and Interest Expense go up and down completely randomly.

Correlation Coefficient

0.29
Relationship DirectionPositive 
Relationship StrengthVery Weak

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.
Most indicators from United Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into United Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.As of 03/28/2024, Selling General Administrative is likely to drop to about 207.3 M. In addition to that, Discontinued Operations is likely to drop to 5,600
 2021 2022 2023 2024 (projected)
Gross Profit1.6B1.8B2.1B2.2B
Total Revenue1.7B1.9B2.3B2.4B

United Therapeutics fundamental ratios Correlations

0.840.240.641.00.97-0.140.97-0.220.850.990.330.920.740.240.560.89-0.30.890.990.920.460.950.990.830.48
0.840.270.370.80.80.260.8-0.250.610.860.20.90.430.130.820.77-0.30.920.80.840.40.820.790.820.51
0.240.27-0.240.220.23-0.180.330.020.330.210.540.420.440.080.510.29-0.550.270.260.230.390.140.190.40.09
0.640.37-0.240.630.69-0.310.57-0.190.610.630.230.360.690.45-0.090.560.020.580.620.480.420.530.650.470.24
1.00.80.220.630.96-0.190.98-0.220.860.980.330.90.740.20.510.88-0.310.850.990.910.420.950.990.810.47
0.970.80.230.690.96-0.180.94-0.150.850.960.430.860.790.40.530.84-0.310.90.960.920.610.880.960.820.55
-0.140.26-0.18-0.31-0.19-0.18-0.260.12-0.59-0.04-0.57-0.01-0.58-0.10.39-0.160.410.12-0.23-0.01-0.270.06-0.170.130.03
0.970.80.330.570.980.94-0.26-0.280.910.940.490.920.780.110.540.91-0.50.830.980.920.450.890.940.750.54
-0.22-0.250.02-0.19-0.22-0.150.12-0.28-0.3-0.19-0.14-0.3-0.210.41-0.11-0.330.34-0.2-0.26-0.130.06-0.2-0.20.020.05
0.850.610.330.610.860.85-0.590.91-0.30.790.630.770.860.20.350.8-0.560.690.890.740.540.680.830.570.41
0.990.860.210.630.980.96-0.040.94-0.190.790.270.90.690.260.580.84-0.250.910.950.920.440.930.970.860.49
0.330.20.540.230.330.43-0.570.49-0.140.630.270.370.660.070.210.42-0.860.310.380.440.650.120.260.140.57
0.920.90.420.360.90.86-0.010.92-0.30.770.90.370.610.110.790.88-0.440.90.910.890.450.890.880.760.44
0.740.430.440.690.740.79-0.580.78-0.210.860.690.660.610.390.210.73-0.480.630.770.590.640.540.740.560.26
0.240.130.080.450.20.4-0.10.110.410.20.260.070.110.390.120.080.360.390.220.130.70.160.310.4-0.07
0.560.820.51-0.090.510.530.390.54-0.110.350.580.210.790.210.120.53-0.320.750.530.620.430.580.50.60.35
0.890.770.290.560.880.84-0.160.91-0.330.80.840.420.880.730.080.53-0.460.810.920.80.40.860.860.650.39
-0.3-0.3-0.550.02-0.31-0.310.41-0.50.34-0.56-0.25-0.86-0.44-0.480.36-0.32-0.46-0.25-0.35-0.44-0.29-0.14-0.21-0.07-0.54
0.890.920.270.580.850.90.120.83-0.20.690.910.310.90.630.390.750.81-0.250.850.840.590.830.860.820.46
0.990.80.260.620.990.96-0.230.98-0.260.890.950.380.910.770.220.530.92-0.350.850.890.460.940.970.780.45
0.920.840.230.480.910.92-0.010.92-0.130.740.920.440.890.590.130.620.8-0.440.840.890.460.880.880.760.73
0.460.40.390.420.420.61-0.270.450.060.540.440.650.450.640.70.430.4-0.290.590.460.460.30.460.460.32
0.950.820.140.530.950.880.060.89-0.20.680.930.120.890.540.160.580.86-0.140.830.940.880.30.940.810.42
0.990.790.190.650.990.96-0.170.94-0.20.830.970.260.880.740.310.50.86-0.210.860.970.880.460.940.820.37
0.830.820.40.470.810.820.130.750.020.570.860.140.760.560.40.60.65-0.070.820.780.760.460.810.820.35
0.480.510.090.240.470.550.030.540.050.410.490.570.440.26-0.070.350.39-0.540.460.450.730.320.420.370.35
Click cells to compare fundamentals

United Therapeutics Account Relationship Matchups

United Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.9B4.6B5.2B6.0B7.2B7.5B
Other Current Liab39.6M319.2M301.6M339.1M71M116.3M
Total Current Liabilities463M323.3M305.4M343.2M804.4M844.6M
Total Stockholder Equity2.8B3.4B4.0B4.8B6.0B6.3B
Property Plant And Equipment Net738.5M731.6M780.9M861.5M1.0B1.1B
Net Debt111.6M61.3M(94.8M)(161.2M)(507.7M)(482.3M)
Retained Earnings3.3B3.8B4.3B5.0B6.0B6.3B
Accounts Payable23.1M9.9M4.1M3.8M5.6M10.2M
Cash738.4M738.7M894.8M961.2M1.2B1.3B
Non Current Assets Total2.0B2.4B2.8B2.7B3.6B3.8B
Non Currrent Assets Other154.6M169.9M108.2M114.3M151.8M91.5M
Cash And Short Term Investments2.3B3.0B3.6B4.2B3.0B3.1B
Net Receivables151.4M157.4M198.7M220.4M278.9M292.8M
Common Stock Shares Outstanding43.8M44.6M47.3M48.5M49.7M50.7M
Liabilities And Stockholders Equity3.9B4.6B5.2B6.0B7.2B7.5B
Non Current Liabilities Total670M896.5M904.8M904.6M377.8M269.4M
Other Current Assets133.8M88.3M100.4M219.2M166.2M174.5M
Other Stockholder Equity(531.3M)(430.5M)(333.8M)(190.8M)(30.2M)(28.7M)
Total Liab1.1B1.2B1.2B1.2B1.2B1.2B
Total Current Assets1.9B2.2B2.3B3.4B3.6B3.7B
Short Term Investments747.5M1.1B1.0B1.9B1.8B1.9B
Property Plant And Equipment Gross738.5M731M1.1B1.2B1.5B1.5B
Intangible Assets130.3M130.1M16.6M16.5M80.5M84.5M
Other Liab67M79.4M104.8M76.8M88.3M60.5M
Other Assets293.8M1.6B370.1M413.5M475.5M284.7M
Inventory93.4M86.5M93.8M102M111.8M55.9M
Property Plant Equipment738.5M731.6M780.9M861.5M990.7M1.0B
Net Tangible Assets2.6B3.2B3.9B4.8B5.5B5.7B
Retained Earnings Total Equity3.3B3.8B4.3B5.0B5.8B6.1B

United Therapeutics Investors Sentiment

The influence of United Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in United. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to United Therapeutics' public news can be used to forecast risks associated with an investment in United. The trend in average sentiment can be used to explain how an investor holding United can time the market purely based on public headlines and social activities around United Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
United Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for United Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average United Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on United Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards United Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, United Therapeutics' short interest history, or implied volatility extrapolated from United Therapeutics options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether United Therapeutics is a strong investment it is important to analyze United Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact United Therapeutics' future performance. For an informed investment choice regarding United Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.
Note that the United Therapeutics information on this page should be used as a complementary analysis to other United Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for United Stock analysis

When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is United Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of United Therapeutics. If investors know United will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about United Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.626
Earnings Share
19.8
Revenue Per Share
49.733
Quarterly Revenue Growth
0.251
Return On Assets
0.1122
The market value of United Therapeutics is measured differently than its book value, which is the value of United that is recorded on the company's balance sheet. Investors also form their own opinion of United Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is United Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because United Therapeutics' market value can be influenced by many factors that don't directly affect United Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between United Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if United Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, United Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.